InMed Pharmaceuticals Coefficient Of Variation
| INM Stock | | | USD 0.70 -0.03 -4.11% |
Coefficient of Variation (CV) is a normalized measure of dispersion that relates volatility to expected return, making it a useful indicator of risk per unit of return. It is also referred to as relative standard deviation when expressed as a percentage. Below is InMed Pharmaceuticals's current Coefficient Of Variation with peer comparisons and related risk metrics.
Current Coefficient Of Variation Value
At
-1,544, InMed Pharmaceuticals's Coefficient Of Variation indicates that InMed Pharmaceuticals's expected return over the measured period is negative, meaning volatility is not being compensated by positive performance. The magnitude of this value is unusually large in absolute terms, suggesting an unstable or weak relationship between risk and return, often driven by low or near-zero expected returns.
Coefficient Of Variation | = | STDER |
| = | -1,544 | |
Coefficient Of Variation Peers Comparison
Among sector peers, InMed Pharmaceuticals's Coefficient Of Variation of -1543.5351 is below the 165.62 group average. The range runs from -5404.7235 (Biodexa Pharmaceticals) to 3540.74 (Estrella Immunopharma). Relative to peers, InMed Pharmaceuticals's current CV suggests a less favorable risk-return profile over the measured period, as volatility has not translated into positive expected returns.
Coefficient Of Variation Relative To Other Indicators
The chart below plots Coefficient Of Variation against Maximum Drawdown for InMed Pharmaceuticals and its peers. Each point represents one equity — position along the horizontal axis shows Coefficient Of Variation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Compare InMed Pharmaceuticals to PeersMethodology, Assumptions & Data Sources
The current Coefficient Of Variation for InMed Pharmaceuticals is -1,544. This Coefficient Of Variation reading for InMed Pharmaceuticals results from applying the indicator's calculation rules to price and volume data over the selected window. Data sources include daily closing prices from supported exchanges, with standard corporate action adjustments applied. The calculation assumes continuous price data across the selected period. All readings are presented as reference data.
Other Technical Indicators